Iterum Therapeutics plc (ITRM) |
| 0.326 -0.01 (-2.98%) 01-14 16:00 |
| Open: | 0.3293 |
| High: | 0.3491 |
| Low: | 0.3234 |
| Volume: | 203,703 |
| Market Cap: | 17(M) |
| PE Ratio: | -0.45 |
| Exchange: | NASDAQ Capital Market |
| Industry: | Biotechnology |
| Sector: | Healthcare |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 0.49 |
| Resistance 1: | 0.40 |
| Pivot price: | 0.33 |
| Support 1: | 0.26 |
| Support 2: | 0.22 |
| 52w High: | 1.75 |
| 52w Low: | 0.26 |
Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and IV formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract infections, complicated urinary tract infections, and complicated intra-abdominal infections. The company was incorporated in 2015 and is headquartered in Dublin, Ireland.
Financials
| EPS | -19320000.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | -1.00 |
| Return on Assets (ttm) | 982.3 |
| Return on Equity (ttm) | -53.3 |
Company news
Tue, 23 Dec 2025
Iterum Therapeutics expands market access for ORLYNVAH antibiotic - Investing.com
Wed, 17 Dec 2025
Iterum Therapeutics secures major PBM agreement for antibiotic - Investing.com
Wed, 17 Dec 2025
New PBM deal could open ORLYNVAH access to 40M more people in 2026 - Stock Titan
Fri, 05 Dec 2025
Iterum Therapeutics (Nasdaq: ITRM) inks Medicare Part D deal, EU patent to 2039 - Stock Titan
Fri, 14 Nov 2025
Iterum Therapeutics (Nasdaq: ITRM) extends cash runway into Q2 2026; Q3 revenue $0.4M - Stock Titan
Fri, 14 Nov 2025
Iterum Therapeutics PLC (ITRM) Q3 2025 Earnings Call Highlights: Launch Success and Financial ... - Yahoo Finance
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
